BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 32453263)

  • 21. Adjustment of azathioprine dose should be based on a lower 6-TGN target level to avoid leucopenia in NUDT15 intermediate metabolisers.
    Kang B; Kim TJ; Choi J; Baek SY; Ahn S; Choi R; Lee SY; Choe YH
    Aliment Pharmacol Ther; 2020 Aug; 52(3):459-470. PubMed ID: 32598049
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Population impact of pharmacogenetic tests in admixed populations across the Americas.
    Suarez-Kurtz G
    Pharmacogenomics J; 2021 Apr; 21(2):216-221. PubMed ID: 33110249
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NUDT15 and TPMT genetic polymorphisms are related to 6-mercaptopurine intolerance in children treated for acute lymphoblastic leukemia at the Children's Cancer Center of Lebanon.
    Zgheib NK; Akika R; Mahfouz R; Aridi CA; Ghanem KM; Saab R; Abboud MR; Tarek N; El Solh H; Muwakkit SA
    Pediatr Blood Cancer; 2017 Jan; 64(1):146-150. PubMed ID: 27577869
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NUDT15: A bench to bedside success story.
    Moyer AM
    Clin Biochem; 2021 Jun; 92():1-8. PubMed ID: 33675810
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NUDT15 gene polymorphism related to mercaptopurine intolerance in Taiwan Chinese children with acute lymphoblastic leukemia.
    Liang DC; Yang CP; Liu HC; Jaing TH; Chen SH; Hung IJ; Yeh TC; Lin TH; Lai CL; Lai CY; Shih LY
    Pharmacogenomics J; 2016 Nov; 16(6):536-539. PubMed ID: 26503813
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comprehensive characterization of pharmacogenetic variants in TPMT and NUDT15 in children with acute lymphoblastic leukemia.
    Moriyama T; Yang W; Smith C; Pui CH; Evans WE; Relling MV; Bhatia S; Yang JJ
    Pharmacogenet Genomics; 2022 Feb; 32(2):60-66. PubMed ID: 34412101
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of Genetic Variants in NUDT15 With Thiopurine-Induced Myelosuppression in Patients With Inflammatory Bowel Disease.
    Walker GJ; Harrison JW; Heap GA; Voskuil MD; Andersen V; Anderson CA; Ananthakrishnan AN; Barrett JC; Beaugerie L; Bewshea CM; Cole AT; Cummings FR; Daly MJ; Ellul P; Fedorak RN; Festen EAM; Florin TH; Gaya DR; Halfvarson J; Hart AL; Heerasing NM; Hendy P; Irving PM; Jones SE; Koskela J; Lindsay JO; Mansfield JC; McGovern D; Parkes M; Pollok RCG; Ramakrishnan S; Rampton DS; Rivas MA; Russell RK; Schultz M; Sebastian S; Seksik P; Singh A; So K; Sokol H; Subramaniam K; Todd A; Annese V; Weersma RK; Xavier R; Ward R; Weedon MN; Goodhand JR; Kennedy NA; Ahmad T;
    JAMA; 2019 Feb; 321(8):773-785. PubMed ID: 30806694
    [TBL] [Abstract][Full Text] [Related]  

  • 28.
    Moradveisi B; Muwakkit S; Zamani F; Ghaderi E; Mohammadi E; Zgheib NK
    Front Pharmacol; 2019; 10():916. PubMed ID: 31507415
    [No Abstract]   [Full Text] [Related]  

  • 29. Identification of NUDT15 gene variants in Amazonian Amerindians and admixed individuals from northern Brazil.
    Rodrigues JCG; Souza TP; Pastana LF; Ribeiro Dos Santos AM; Fernandes MR; Pinto P; Wanderley AV; Souza SJ; Kroll JE; Pereira AL; Magalhães L; Mercês LRD; Vidal AF; Vinasco-Sandoval T; Cavalcante GC; Guerreiro JF; Assumpção PP; Ribeiro-Dos-Santos Â; Santos S; Santos NPCD
    PLoS One; 2020; 15(4):e0231651. PubMed ID: 32294118
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cost-effectiveness analysis of pretreatment screening for NUDT15 defective alleles.
    Zarca K; Chansavang A; Loriot MA; Durand-Zaleski I; Pallet N
    Pharmacogenet Genomics; 2020 Oct; 30(8):175-183. PubMed ID: 32433339
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Further evidence that a variant of the gene NUDT15 may be an important predictor of azathioprine-induced toxicity in Chinese subjects: a case report.
    Ailing Z; Jing Y; Jingli L; Yun X; Xiaojian Z
    J Clin Pharm Ther; 2016 Oct; 41(5):572-4. PubMed ID: 27381176
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Susceptibility to thiopurine toxicity by
    Correa-Jimenez O; Yunis JJ; Linares-Ballesteros A; Sarmiento-Urbina I
    Colomb Med (Cali); 2021; 52(3):e2074569. PubMed ID: 35431360
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TPMT and ITPA genetic variants in Lithuanian inflammatory bowel disease patients: Prevalence and azathioprine-related side effects.
    Steponaitiene R; Kupcinskas J; Survilaite S; Varkalaite G; Jonaitis L; Kiudelis G; Denapiene G; Valantinas J; Skieceviciene J; Kupcinskas L
    Adv Med Sci; 2016 Mar; 61(1):135-40. PubMed ID: 26674571
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Role of TPMT, ITPA, and NUDT15 Variants during Mercaptopurine Treatment of Swedish Pediatric Patients with Acute Lymphoblastic Leukemia.
    Wahlund M; Nilsson A; Kahlin AZ; Broliden K; Myrberg IH; Appell ML; Berggren A
    J Pediatr; 2020 Jan; 216():150-157.e1. PubMed ID: 31635813
    [TBL] [Abstract][Full Text] [Related]  

  • 35. NUDT15 polymorphisms are better than thiopurine S-methyltransferase as predictor of risk for thiopurine-induced leukopenia in Chinese patients with Crohn's disease.
    Zhu X; Wang XD; Chao K; Zhi M; Zheng H; Ruan HL; Xin S; Ding N; Hu PJ; Huang M; Gao X
    Aliment Pharmacol Ther; 2016 Nov; 44(9):967-975. PubMed ID: 27604507
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A direct sequencing assay for pharmacogenetic testing of thiopurine-intolerant NUDT15 alleles in an Asian population.
    Poon KS; Imran IIB; Chew SK; Tan P; Tan KM
    BMC Res Notes; 2022 Apr; 15(1):148. PubMed ID: 35468862
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    Pai AA; Mohan A; Benjamin ESB; Illangeswaran RSS; Xavier Raj I; Janet NB; Arunachalam AK; Kavitha ML; Kulkarni U; Devasia AJ; Fouzia NA; Abraham A; Srivastava A; George B; Mathews V; Korula A; Balasubramanian P
    Pharmgenomics Pers Med; 2021; 14():1303-1313. PubMed ID: 34629890
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genomewide Approach Validates Thiopurine Methyltransferase Activity Is a Monogenic Pharmacogenomic Trait.
    Liu C; Yang W; Pei D; Cheng C; Smith C; Landier W; Hageman L; Chen Y; Yang JJ; Crews KR; Kornegay N; Karol SE; Wong FL; Jeha S; Sandlund JT; Ribeiro RC; Rubnitz JE; Metzger ML; Pui CH; Evans WE; Bhatia S; Relling MV
    Clin Pharmacol Ther; 2017 Mar; 101(3):373-381. PubMed ID: 27564568
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of TPMT, ITPA and NUDT 15 genetic polymorphisms and their relation to 6MP toxicity in north Indian children with acute lymphoblastic leukemia.
    Khera S; Trehan A; Bhatia P; Singh M; Bansal D; Varma N
    Cancer Chemother Pharmacol; 2019 Feb; 83(2):341-348. PubMed ID: 30474703
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of Direct Sequencing, Real-Time PCR-High Resolution Melt (PCR-HRM) and PCR-Restriction Fragment Length Polymorphism (PCR-RFLP) Analysis for Genotyping of Common Thiopurine Intolerant Variant Alleles NUDT15 c.415C>T and TPMT c.719A>G (TPMT*3C).
    Fong WY; Ho CC; Poon WT
    Diagnostics (Basel); 2017 May; 7(2):. PubMed ID: 28498350
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.